Background: Frailty is an independent predictor of mortality across many conditions. Reported rates of frailty in heart failure range from 15% to 74%. There are several instruments available to assess frailty; however, to date there has been no consensus on the most appropriate instrument for use in individuals with heart failure. Aims: To identify how frailty is assessed in individuals with heart failure and to elucidate which domains of frailty are most frequently assessed. Methods: Key electronic databases were searched (MEDLINE, COCHRANE Central and CINAHL) to identify studies that assessed frailty in individuals with heart failure using a formal frailty instrument. Results: Twenty studies published in 24 articles were included, for which a total of seven unique frailty instruments were identified. The most commonly used instrument was the Frailty Phenotype (n= 11), with the majority of studies using a modified version of the Frailty Phenotype (n= 8). The second most commonly used instrument identified was the Comprehensive Geriatric Assessment (n= 4).
Introduction
Frailty is a multidimensional syndrome characterized by a state of increased vulnerability to acute stressors, such as hospitalization, falls and infection. It is an independent predictor of mortality 1, 2 and is the most problematic expression of population ageing. 3 With growing focus on multimorbidity, this construct has increasing utility. 4 Frailty is most commonly defined as meeting three out of five phenotypic criteria: low physical activity, unintentional weight loss, slow walking speed, weak grip strength, and/or exhaustion. 5 Heart failure is a common yet complex cardiac syndrome, developing as a result of structural or functional damage to the heart which reduces its ability to fill with and/or pump blood effectively. 6, 7 The prevalence of heart failure increases significantly with age 8 and is associated with high morbidity and mortality. 9, 10 Heart failure is a leading cause of hospitalization and general practitioner consultation, particularly in the elderly population. 10 The high prevalence of frailty in heart failure is well documented [11] [12] [13] and as such it has been identified as an emergent area of research priority. 14 The reason for this is complex and multifaceted. Some of these considerations are determining prognosis and assisting in the assessment of therapies, particularly those that are invasive. 15 Frailty has been shown to predict adverse outcomes in heart failure. 12, 16, 17 However, the variability in defining frailty and the use of diverse measures have made it problematic to compare the prevalence of frailty and its impact on outcomes between studies.
Aims
The purpose of this review was to examine how frailty is assessed in individuals with heart failure.
The four key objectives of this review are:
(a) Summarize the available instruments that have been used for frailty measurement in heart failure; (b) Highlight the core domains of frailty assessments; (c) Identify the strengths and limitations of the instruments; (d) Discuss implications for future heart failure clinical research and practice.
Methods
Following consultation with a health librarian, key electronic health related databases (MEDLINE and CINAHL and the COCHRANE Central) were searched from 2001 to 2016. In 2001, Fried published her seminal paper on the impact of frailty in cardiovascular disease; 5 accordingly it was selected as the start point for this review. Search terms included are listed in Table 1 . Original studies were selected that included participants with a diagnosis of heart failure, that is, individuals exhibiting heart failure symptoms or receiving treatment for heart failure, and studies must have addressed measurement of frailty using a structured instrument. Only original studies were included; conference abstracts, reviews and editorials were excluded. First, articles were extracted from the electronic database. Following this, they were screened against the eligibility criteria based on title/abstract. Articles then underwent full text review by two independent researchers (JM and LM); where necessary a third researcher (PJN) was consulted. In the case of multiple studies drawn from the same data set, the original paper was included in the summary table.
The review was conducted in accordance with the PRISMA guidelines. 18 
Quality assessment of included studies
Quality assessment of included studies was undertaken by two independent reviewers in accordance with the Joanna Briggs Institute (JBI) Critical Appraisal Checklists for case control studies, studies reporting prevalence data, cohort studies and randomized control studies outlined in the JBI Reviewers' Manual: 2014 edition (see Supplementary Material online, Tables 1-4) . 19 To the authors' knowledge the included articles also conformed to the standards outlined in the Declaration of Helsinki. 20 Due to heterogeneity of frailty assessment among the included articles metaanalysis was not performed. Results are summarized in tabular and narrative form.
Results
The search strategy retrieved a total of 740 articles. Following the removal of duplicates, 699 were screened. From this, 664 were excluded based on inappropriate title/abstract with the remaining 35 undergoing full-text review. After consensus was gained, 24 articles were included in this review (Figure 1) . Seven different frailty instruments were identified from the 24, and from these 20 were identified as original studies. The most commonly utilized frailty instruments (n=11 (55%)) were based on Frailty Phenotype (FP), 5 with the majority (n=8) using modified versions of the original tool 17, [21] [22] [23] [24] [25] [26] [27] [28] with one study assessing a single-item component. 29 The second most commonly utilized instrument was the Comprehensive Geriatric Assessment (CGA) (n= 4), followed by the Deficit Accumulation Index (DAI) (n=2). A summary of the results from each study 11, 12, 16, 17, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and the instrument utilized is provided in Table 2 . 
Discussion

Frailty assessment instruments identified
The FP. The FP defines frailty as a biological syndrome that causes age related physical decline. This scale focuses on five physical components of frailty (exhaustion, physical inactivity, walking speed, grip strength, and weight loss 41 ) and was first developed as part of the Cardiovascular Health Study. 42 The FP has become one of the most well-known definitions, and is consistently identified as the most commonly used measure throughout the literature. 43 Whilst it has been used in numerous heart failure studies, the definition was originally validated in community dwelling older adults. The FP consists of a series to be performed by a clinician. These include: measurement of hand grip strength as assessed by a dynamometer and a five-metre gait speed test alongside self-reported measures regarding weight loss, exercise tolerance and physical activity. Whilst the FP is the most commonly used instrument, it has been questioned whether all five domains of the FP are necessary, or whether a single measure is equally effective. 44, 45 Reduced hand grip strength and five-metre gait speed have been recommended as predictive singleitem measures of frailty. 1 Frailty instruments that measure multiple domains are often time consuming to complete and as such may not be feasible in a time constrained, acute clinical environment. Therefore, the use of a singleitem measure may be more appropriate. Using hand grip strength as a measure of frailty in a cohort of individuals with heart failure undergoing ventricular assist device (VAD) implantation demonstrated that individuals with reduced hand grip strength pre VAD implant had higher rates of post-operative complications and lower survival rates. The use of hand grip strength was favoured over a full functional assessment in this cohort due to their minimal tolerance to undertake physical exertion and their disease related deconditioning, which is common in heart failure patients. 29 A limitation of hand grip strength as a single measure is that there may be certain individuals who are unable to perform a hand grip strength measurement, such as: those with hemiplegia, individuals unable to follow commands due to advanced dementia or other cognitive illness, those post sternotomy or permanent pace maker insertion and individuals with altered level of consciousness.
Modified FP. A number of studies included in this review used a form of modified FP. 21, 22, 26 All the versions of the FP used in these studies have variations from the original FP, such as using self-reported measures of appetite in place of weight loss 26 or altering the distance of the walk speed test. 21 These modified versions of the FP have not been validated for routine use in heart failure.
The SHARE Frailty Index (modified FP).
The SHARE Frailty Index (SHARE-FI) was developed as part of Survey of Health Ageing & Retirement in Europe 46 and consists of variables relating to the five domains of the FP. It was designed to offer a valid alternative to the FP in the European context and aimed to facilitate the rapid assessment of frailty in the primary care setting. 47 It was validated in a cohort of community dwelling adults and provides a gender-specific frailty class. It is relatively similar to the FP, with the exception of weight loss and slowness, the 'weight loss' criteria being replaced with self-reported measures related to appetite and the 'slowness' component assessed using questions regarding functional limitation rather than the five metre gait speed test. 5, 47 The SHARE-FI has been piloted in various clinical settings 48 but has only had very limited use in heart failure 25, 28 and is currently not validated for routine use in this group.
The CGA scale. The CGA was first developed by Marjory Warren in the 1930s 49, 50 as a method of structured assessment of an elderly person's psychosocial, medical, functional and environmental needs in an attempt to improve their treatment and follow-up plans. 51 The modern CGA involves the use of previously validated geriatric scales, that is, the Barthel Index of Activities of Daily Living, 52 the Older Americans Resource and Services (OARS) scale, 53 the Pfeiffer cognitive test 54 and the Yesavage geriatric depression scale. 55 The use of the CGA is highly cited in the literature, particularly in the cancer care specialty. [56] [57] [58] The CGA has been validated for use as a frailty measurement tool in the general geriatric population 59 and has consistently demonstrated reliability for measuring frailty in various heart failure populations. 16, 30, 34 It provides a multidimensional team approach to measure functional, social and cognitive domains of frailty, 13 including disability and comorbidities, which have otherwise been acknowledged as related yet independent syndromes. The CGA and the FP both include self-reported patient questions and multiple assessments and, as such, may be considered too time intensive for routine use in the clinical setting.
The DAI. The DAI (also known as the Frailty Index) conceptualizes frailty as an accumulation of deficits. The DAI 60 was developed using data from the Canadian Study of Health and Ageing 61 and includes the assessment of multiple variables, including: 1) self-care ability; 2) dependence on assistive devices; 3) medical conditions; 4) body mass index and; 5) depression. It is designed so that many of the variables can be extracted from the patient medical records, therefore, the DAI may be more appropriate for the time-poor clinician. The benefit of the DAI over the FP is that it assesses various domains of human functioning, as opposed to only physical domains. In the context of heart failure, the DAI has been used in preoperative adults (mean age 65 years) undergoing left VAD implantation as destination therapy 33 and in a cohort of community dwelling older adults (mean age 71 years) 11 with a combined total of 222 patients. The DAI demonstrated correlation with the FP and was equally able to predict mortality 11 in a heart failure population. It is yet to be formally validated for use in heart failure.
Tilburg Frailty Indicator. The Tilburg Frailty Indicator (TFI) is based on a definition that frailty is a consequence of a combination of life course determinants and diseases leading to a decline in various domains of physical, psychological and social functioning which ultimately causes adverse outcomes such as disability, health care utilization and death. 62 The TFI consists of two parts: the first comprises variables related to the socio-demographic characteristics of the participant and the second comprises 15 self-reported questions divided into physical, psychological and social domains. 40 The TFI has previously demonstrated validity and reliability in a cohort of 484 community-dwelling persons aged 75 years and older. 62 It has not yet been validated for use in a heart failure population.
Frailty Staging System. The Frailty Staging System (FSS) was modified from a previous examination method used to assess elderly patients for functional disability. 63 It shortens the original 15 target areas down to seven core domains of functioning: disability, mobility, cognitive function, visual function, hearing function, urinary continence and social support. 12 The FSS has not been validated in a heart failure population.
Canadian Study of Health and Ageing Clinical Frailty Scale. The Canadian Study of Health and Ageing Clinical Frailty
Scale (CSHA-CFS) is a seven point frailty scale that was applied to 2305 individuals aged greater than 65 years who participated in the second stage of the CSHA. 61, 64 CSHA-CFS is a frailty rating score and ranges from Very Fit to Severely Frail. Whilst the CSHA-CFS was able to provide predictive information regarding mortality or the need for institutionalization in this group, 64 it has limited applicability to the heart failure population and has yet to be validated in this group.
There are several different instruments used to assess frailty in individuals with heart failure. However, to date none of these have been formally validated for use in this population. Due to the lack of validated frailty instruments in previous heart failure clinical research, caution should be exercised when interpreting the rates of frailty as they may be over or underestimated. This review has also demonstrated the inconsistencies in frailty assessment and the focus on physical frailty over multi-domain assessment in heart failure. Similar inconsistencies have been found in other areas of cardiovascular disease including, valvular heart disease. 65 The majority of studies included in this review have assessed frailty in community dwelling individuals or outpatients with heart failure, rather than inpatients, therefore there is insufficient data for comparison and there is no consensus about which time-point is most appropriate. Heart failure has been reported to be the most common cause of hospital admission in the elderly, 66, 67 therefore, an opportunity exists for frailty screening to be undertaken within this large number of patients whilst they are hospitalized. This does, however, raise the question of what happens to frailty over time and whether an individual's frailty status changes when they are acutely unwell as opposed to post discharge. The hypothesis that an individual's frailty status would be worse when they are acutely unwell, and therefore it may be inappropriate to measure at this stage, has yet to be tested in the heart failure population.
The frailty domain most commonly assessed in this group is physical function/mobility. All seven frailty instruments include a question regarding physical function and three instruments include an objective gait speed test or hand grip strength measurement. An overview of the various domains of frailty that are assessed in each instrument is provided in Table 3 .
Individuals with heart failure often experience disease related deconditioning and decreased exercise tolerance which may be worse at periods of acute decompensation and hospitalization; 9 during this time it may affect their ability to perform a physical assessment and/or hand grip strength measurement. The duration of hospitalization should also be taken into consideration, that is, if the hospitalization was only one or two days, would this affect the accuracy of the frailty measurement less compared with a longer hospitalization of greater than seven days? An individual's appetite may also be difficult to assess when they are acutely unwell and hospitalized due to the disruption of their normal dietary habits. Furthermore, questions related to unintentional weight loss may also be difficult to assess in heart failure as individuals are often fluid overloaded, leading to frequent changes in weight.
To the authors' knowledge, this is the first review that has focused on the frailty assessment instruments in heart failure and the first to provide an overview of the most frequently assessed domains of frailty in this population. It is hoped that this review will help to guide future research and clinical practice in the most appropriate instrument and domains to address when assessing frailty in heart failure.
Conclusion
The assessment of frailty in heart failure is an emergent research priority and is often used as an important prognostic indicator in the clinical setting. This review has highlighted the need for a validated and clinically relevant frailty assessment instrument for use in a heart failure population. Further research is also needed to gain consensus on the most appropriate time to assess for frailty in this group and to elucidate whether there are significant differences in inpatient or outpatient assessment. The impact that disease related deconditioning or progression of heart failure symptoms may have on frailty assessment also needs to be explored in future research and the most reliable frailty domains for assessment should be chosen. Routine assessment of frailty as part of a holistic treatment plan for heart failure patients should be considered. Nurses are well placed in the acute and primary health care setting to undertake this assessment. It is imperative that frailty is being accurately and precisely assessed in this group with a validated instrument.
Implications for practice
• • There are no validated frailty instruments available for use in heart failure. • • This review identifies that all frailty instruments assess physical function or mobility. • • Potential exists for routine frailty screening in heart failure in combination with other standardized methods of assessment. • • Nurses are appropriately skilled to undertake this screening as part of physical assessment and this is a fertile area for future research.
